CVS beats estimates, but cuts full-year profit outlook on higher medical costs

The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share. 

Previous post Treasury yields a touch lower as bond markets reconcile to no March Fed rate cut
Next post Hilton’s stock slides premarket after 2024 guidance falls short of estimates